Preceding pain symptoms and Parkinson's disease: A nationwide population-based cohort study

European Journal of Neurology

Volumn 20, Issue 10, 2013, Pages 1398-1404

  Lin, C H ^a   Wu, R M ^a   Chang, H Y ^b   Chiang, Y T ^c   Lin, H H ^c  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Ibuprofen; Non steroidal anti inflammatory drugs; Pain; Parkinson's disease

Indexed keywords

IBUPROFEN;

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ARTHRALGIA; ARTICLE; COFFEE; COHORT ANALYSIS; COMORBIDITY; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG USE; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NECK PAIN; PAIN; PARKINSON DISEASE; PHYSICAL ACTIVITY; POPULATION RESEARCH; PRIORITY JOURNAL; RISK FACTOR; SEX; SMOKING; TEA;

IBUPROFEN; NON-STEROIDAL ANTI-INFLAMMATORY DRUGS; PAIN; PARKINSON'S DISEASE;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; COHORT STUDIES; DATA COLLECTION; FEMALE; HUMANS; IBUPROFEN; INCIDENCE; MALE; MIDDLE AGED; PAIN; PARKINSON DISEASE; RISK FACTORS; TAIWAN;

EID: 84883773708     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/ene.12197     Document Type: Article

References (35)

1. Winter Y, von Campenhausen S, Brozova H, et al. Costs of Parkinson's disease in eastern Europe: a Czech cohort study. Parkinsonism Relat Disord 2010; 16: 51-56.
2. Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol 1999; 56: 33-39.
3. Koller WC. Sensory symptoms in Parkinson's disease. Neurology 1984; 34: 957-959.
4. Snider SR, Fahn S, Isgreen WP, Cote LJ. Primary sensory symptoms in parkinsonism. Neurology 1976; 26: 423-429.
5. Giuffrida R, Vingerhoets FJ, Bogousslavsky J, Ghika J. Pain in Parkinson's disease. Rev Neurol(Paris) 2005; 161: 407-418.
6. Djaldetti R, Shifrin A, Rogowski Z, Sprecher E, Melamed E, Yarnitsky D. Quantitative measurement of pain sensation in patients with Parkinson disease. Neurology 2004; 62: 2171-2175.
7. Kanda T, Tsukagoshi H, Oda M, Miyamoto K, Tanabe H. Changes of unmyelinated nerve fibers in sural nerve in amyotrophic lateral sclerosis, Parkinson's disease and multiple system atrophy. Acta Neuropathol 1996; 91: 145-154.
8. Zia S, Cody FW, O'Boyle DJ. Discrimination of bilateral differences in the loci of tactile stimulation is impaired in subjects with Parkinson's disease. Clin Anat 2003; 16: 241-247.
9. Lewis GN, Byblow WD. Altered sensorimotor integration in Parkinson's disease. Brain 2002; 125: 2089-2099.
10. Defazio G, Berardelli A, Fabbrini G, et al. Pain as a nonmotor symptom of Parkinson disease: evidence from a case-control study. Arch Neurol 2008; 65: 1191-1194.
11. Bower JH, Maraganore DM, Peterson BJ, Ahlskog JE, Rocca WA. Immunologic diseases, anti-inflammatory drugs, and Parkinson disease: a case-control study. Neurology 2006; 67: 494-496.
12. Chen H, Jacobs E, Schwarzschild MA, et al. Nonsteroidal antiinflammatory drug use and the risk for Parkinson's disease. Ann Neurol 2005; 58: 963-967.
13. Bornebroek M, de Lau LM, Haag MD, et al. Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease. Neuroepidemiology 2007; 28: 193-196.
14. Driver JA, Logroscino G, Lu L, Gaziano JM, Kurth T. Use of non-steroidal anti-inflammatory drugs and risk of Parkinson's disease: nested case-control study. BMJ 2011; 342: d198.
15. Hancock DB, Martin ER, Stajich JM, et al. Smoking, caffeine, and nonsteroidal anti-inflammatory drugs in families with Parkinson disease. Arch Neurol 2007; 64: 576-580.
16. Powers KM, Kay DM, Factor SA, et al. Combined effects of smoking, coffee, and NSAIDs on Parkinson's disease risk. Mov Disord 2008; 23: 88-95.
17. Ton TG, Heckbert SR, Longstreth WT Jr, et al. Nonsteroidal anti-inflammatory drugs and risk of Parkinson's disease. Mov Disord 2006; 21: 964-969.
18. Wahner AD, Bronstein JM, Bordelon YM, Ritz B.Nonsteroidal anti-inflammatory drugs may protect against Parkinson disease. Neurology 2007; 69: 1836-1842.
19. Rees K, Stowe R, Patel S, et al. Non-steroidal anti-inflammatory drugs as disease-modifying agents for Parkinson's disease: evidence from observational studies. Cochrane Database Syst Rev 2011; 11: CD008454.
20. Yu ST, Chang HY, Lin MC, Lin YH. Agreement between self-reported and health insurance claims on utilization of health care: a population study. J Clin Epidemiol 2009; 62: 1316-1322.
21. Shih YT, Hung YT, Chang HS, et al. The design, contents, operation and the characteristics of the respondents of the 2001 National Health Interview Survey in Taiwan. Taiwan J Public Health 2003; 22: 419-430.
22. Korn EL, Graubard BI, Midthune D. Time-to-event analysis of longitudinal follow-up of a survey: choice of the time-scale. Am J Epidemiol 1997; 145: 72-80.
23. Goetz CG, Tanner CM, Levy M, Wilson RS, Garron DC. Pain in Parkinson's disease. Mov Disord 1986; 1: 45-49.
24. Tinazzi M, Del Vesco C, Fincati E, et al. Pain and motor complications in Parkinson's disease. J Neurol Neurosurg Psychiatry 2006; 77: 822-825.
25. Etchepare F, Rozenberg S, Mirault T, et al. Back problems in Parkinson's disease: an underestimated problem. Joint Bone Spine 2006; 73: 298-302.
26. Starkstein SE, Preziosi TJ, Robinson RG. Sleep disorders, pain, and depression in Parkinson's disease. Eur Neurol 1991; 31: 352-355.
27. Beiske AG, Loge JH, Ronningen A, Svensson E. Pain in Parkinson's disease: prevalence and characteristics. Pain 2009; 141: 173-177.
28. Braak H, Del Tredici K. Invited Article: nervous system pathology in sporadic Parkinson disease. Neurology 2008; 70: 1916-1925.
29. Braak H, Del Tredici K, Rüb U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003; 24: 197-211.
30. Hawkes CH, Del Tredici K, Braak H. A timeline for Parkinson's disease. Parkinsonism Relat Disord 2010; 16: 79-84.
31. Burnett A, Gebhart GF. Characterization of descending modulation of nociception from the A5 cell group. Brain Res 1991; 546: 271-281.
32. Buzas B, Max MB. Pain in Parkinson disease. Neurology 2004; 62: 2156-2157.
33. Samii A, Etminan M, Wiens MO, Jafari S. NSAID use and the risk of Parkinson's disease: systematic review and meta-analysis of observational studies. Drugs Aging 2009; 26: 769-779.
34. Chen RC, Chang SF, Su CL, et al. Prevalence, incidence, and mortality of PD: door-to-door survey in Ilan county, Taiwan. Neurology 2001; 57: 1679-1686.
35. Gonera EG, van't Hof M, Berger HJ, van Weel C, Horstink MW. Symptoms and duration of the prodromal phase in Parkinson's disease. Mov Disord 1997; 12: 871-876.